(Adds forecast, details)
Nov 4 (Reuters) - Medical equipment maker Becton Dickinson &Co reported better-than-expected profit and revenue,helped by strong sales in its diabetes care and drug-deliverybusinesses.
Becton said it expected adjusted earnings from continuingoperations to be between $6.76 and $6.83 per share for the yearending September 2015.
Analysts on average were expecting $6.70 per share,according to Thomson Reuters I/B/E/S.
Becton, which makes products such as disposable needles,syringes and catheters to administer drugs, last month said itwould buy CareFusion Corp, whose products includeinfusion pumps, to create a market leader in the $20 billionmedication management industry.
Becton said it expected revenue to rise 4.5-5 percent on aforeign currency neutral basis for the year ending Sept. 30,2015. The company reported revenue of $8.45 billion this year.
Net income rose to $301 million, or $1.53 per share, in thefourth quarter, from $91 million, or 46 cents per share, a yearearlier.
The year-ago quarter included pretax charges of $347million.
On an adjusted basis, the company earned $1.68 per share,exceeding the average analyst estimate of $1.65.
Revenue rose 4.8 percent to $2.20 billion, above analysts'average estimate of $2.16 billion. (Reporting by Ankur Banerjee in Bangalore and Susan Kelly inChicago; Editing by Sriraj Kalluvila)
Nov 4 (Reuters) - Medical equipment maker Becton Dickinson &Co reported better-than-expected profit and revenue,helped by strong sales in its diabetes care and drug-deliverybusinesses.
Becton said it expected adjusted earnings from continuingoperations to be between $6.76 and $6.83 per share for the yearending September 2015.
Analysts on average were expecting $6.70 per share,according to Thomson Reuters I/B/E/S.
Becton, which makes products such as disposable needles,syringes and catheters to administer drugs, last month said itwould buy CareFusion Corp, whose products includeinfusion pumps, to create a market leader in the $20 billionmedication management industry.
Becton said it expected revenue to rise 4.5-5 percent on aforeign currency neutral basis for the year ending Sept. 30,2015. The company reported revenue of $8.45 billion this year.
Net income rose to $301 million, or $1.53 per share, in thefourth quarter, from $91 million, or 46 cents per share, a yearearlier.
The year-ago quarter included pretax charges of $347million.
On an adjusted basis, the company earned $1.68 per share,exceeding the average analyst estimate of $1.65.
Revenue rose 4.8 percent to $2.20 billion, above analysts'average estimate of $2.16 billion. (Reporting by Ankur Banerjee in Bangalore and Susan Kelly inChicago; Editing by Sriraj Kalluvila)
via Smart Health Shop Forum http://ift.tt/1E0TmL9
No comments:
Post a Comment